Dust mite asthma study aims to uncover how dupilumab works inside the body
NCT ID NCT05720325
First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times
Summary
This study looks at how dupilumab changes the way the nose and blood respond to house dust mites in adults with allergic asthma. Participants will be exposed to dust mites in a special chamber and receive either dupilumab or a placebo. The goal is to understand the drug's effects on gene activity, not to directly treat symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Biogenics Research Chamber
San Antonio, Texas, 78229, United States
-
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ancient herbal blend put to the test against hay fever
- Can a pinpoint pollen dose unmask allergy triggers?
- Can an antihistamine–steroid combo pill beat standard allergy meds?
- Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
- Allergy study seeks to pinpoint those most bothered by cats and birch pollen
- Asthma relief in a chew? plant stanols put to the test